CD8 T cells secreting type 2 lymphokines are defective in protection against viral infection

Cellular Immunology

Volumn 202, Issue 1, 2000, Pages 13-22

  Wirth, Susanne ^a   Van Den Broek, Maries ^b   Frossard, Christophe P ^a   Hügin, Ambros W ^a   Leblond, Isabelle ^a   Pircher, Hanspeter ^c   Hauser, Conrad ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CELL ADHESION MOLECULE; LYMPHOKINE; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; EFFECTOR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; VIRUS INFECTION;

ANIMALIA; CHORIOMENINGITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS MUSCULUS; VACCINIA; VACCINIA VIRUS;

EID: 0034713182     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.2000.1639     Document Type: Article

References (43)

1. Abbas A. K., Murphy K. M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. + T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1992;1652-1656.
3. - cells that make TH2 cytokines and help B cells. Science. 260:1993;1802-1805.
4. Croft M., Carter L., Swain S. L., Dutton R. W. Generation of polarized antigen-specific effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1994;1715-1728.
5. + T cells secreting Th1 or Th2 cytokines. Immunity. 2:1995;271-279.
6. + and their role in the generation of antigen-specific cytotoxic T cells. Eur. J. Immunol. 21:1991;1863-1871.
7. + cells can switch to interleukin 5 production and induce airway eosinophilia. J. Exp. Med. 181:1995;1229-1233.
8. Baumgarth N., Brown L., Jackson D., Kelso A. Novel features of the respiratory tract T-cell response to influenza virus infection: Lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J. Virol. 68:1994;7575-7581.
9. Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convit J., Modlin R. L., Bloom B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 254:1991;279-282.
10. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180:1994;489-495.
11. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K. J., Podack E. R., Zinkernagel R. M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice [see comments]. Nature. 369:1994;31-37.
12. Kagi D., Seiler P., Pavlovic J., Ledermann B., Burki K., Zinkernagel R. M., Hengartner H. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:1995;3256-3262.
13. Karupiah G., Woodhams C. E., Blanden R. V., Ramshaw I. A. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2: Mechanisms of rapid viral clearance in immunocompetent mice. J. Immunol. 147:1991;4327-4332.
14. + T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 10:1991;353-358.
15. Ramsay A. J., Ruby J., Ramshaw I. A. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today. 14:1993;155-157.
16. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M., Aguet M. Immune response in mice that lack the interferon-gamma receptor [see comments]. Science. 259:1993;1742-1745.
17. + T cells to sites of infection. J. Immunol. 154:1995;5293-5301.
18. Pravsgaard Christensen J., Marker O., Thomsen A. R. T-cell-mediated immunity to lymphocytic choriomeningitis virus in beta2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice. J. Virol. 70:1996;8997-9002.
19. Pircher H., Burki K., Lang R., Hengartner H., Zinkernagel R. M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342:1989;559-561.
20. Kyburz D., Aichele P., Speiser D. E., Hengartner H., Zinkernagel R. M., Pircher H. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1993;1956-1962.
21. Jakubowski A., Rosa M. D., Bixler S., Lobb R., Burkly L. C. Vascular cell adhesion molecule (VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor. Cell Adhes. Commun. 3:1995;131-142.
22. Lehmann-Grube F. Lymphocytic choriomeningitis virus. Monogr. Virol. 10:1971;1-173.
23. Hany M., Oehen S., Schulz M., Hengartner H., Mackett M., Bishop D. H., Overton H., Zinkernagel R. M. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol. 19:1989;417-424.
24. Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:1988;97-104.
25. Ljunggren H. G., Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants: Analysis of the mechanism. J. Exp. Med. 162:1985;1745-1759.
26. Carter L. L., Dutton R. W. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J. Immunol. 155:1995;1028-1031.
27. + T cells. J. Immunol. 146:1991;577-584.
28. Espevik T., Nissen M. J. A highly sensitive cell line WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:1986;99-105.
29. Slade S. J., Langhorne J. Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology. 179:1989;353-365.
30. Schumacher J. H., O'Garra A., Shrader B., van Kimmenade A., Bond M. W., Mosmann T. R., Coffman R. L. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent assay. J. Immunol. 141:1988;1576-1581.
31. Battegay M., Cooper S., Althage A., Banziger J., Hengartner H., Zinkernagel R. M. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods. 33:1991;191-198.
32. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. J. Immunol. 146:1991;4301-4307.
33. Ramsdell F., Seaman M. S., Miller R. E., Picha K. S., Kennedy M. K., Lynch D. H. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1994;1545-1553.
34. Moskophidis D., Battegay M., Bruendler M. A., Laine E., Gresser I., Zinkernagel R. M. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68:1994;1951-1955.
35. Muller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
36. McClary H., Koch R., Chisari F. V., Guidotti L. G. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines [in process citation]. J. Virol. 74:2000;2255-2264.
37. Nansen A., Jensen T., Pravsgaard Christensen J., Ørding Andreasen S., Ropke C., Marker O., Thomsen A. R. Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus. J. Immunol. 163:1999;6114-6122.
38. Dustin M. L., Springer T. A. T-cell receptor cross-linking transiently stimulates adhesiveness. Nature. 341:1989;619-624.
39. Schmits R., Kundig T. M., Baker D. M., Shumaker G., Simard J. J., Duncan G., Wakeham A., Shahinian A., van der Heiden A., Bachmann M. F., Ohashi P. S., Mak T. W., Hickstein D. D. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J. Exp. Med. 183:1996;1415-1426.
40. Bachmann M. F., McKall-Faienza K., Schmits R., Bouchard D., Beach J., Speiser D. E., Mak T. W., Ohashi P. S. Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation. Immunity. 7:1997;549-557.
41. Austrup F., Vestweber D., Borges E., Lohning M., Brauer R., Herz U., Renz H., Hallmann R., Scheffold A., Radbruch A., Hamann A. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature. 385:1997;81-83.
42. Borges E., Tietz W., Steegmaier M., Moll T., Hallmann R., Hamann A., Vestweber D. P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J. Exp. Med. 185:1997;573-578.
43. Cerwenka A., Morgan T. M., Harmsen A. G., Dutton R. W. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189:1999;423-430.